We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Should Value Investors Buy Cardinal Health (CAH) Stock?
Read MoreHide Full Article
The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always looking at the latest trends in value, growth, and momentum to find strong picks.
Looking at the history of these trends, perhaps none is more beloved than value investing. This strategy simply looks to identify companies that are being undervalued by the broader market. Value investors use a variety of methods, including tried-and-true valuation metrics, to find these stocks.
Zacks has developed the innovative Style Scores system to highlight stocks with specific traits. For example, value investors will be interested in stocks with great grades in the "Value" category. When paired with a high Zacks Rank, "A" grades in the Value category are among the strongest value stocks on the market today.
Cardinal Health (CAH - Free Report) is a stock many investors are watching right now. CAH is currently sporting a Zacks Rank of #2 (Buy), as well as a Value grade of A. The stock is trading with a P/E ratio of 12.91, which compares to its industry's average of 18.11. CAH's Forward P/E has been as high as 14.81 and as low as 8.75, with a median of 11.06, all within the past year.
Investors will also notice that CAH has a PEG ratio of 1.11. This popular figure is similar to the widely-used P/E ratio, but the PEG ratio also considers a company's expected EPS growth rate. CAH's PEG compares to its industry's average PEG of 1.69. CAH's PEG has been as high as 8.89 and as low as 1.11, with a median of 2, all within the past year.
Another great Medical - Dental Supplies stock you could consider is McKesson (MCK - Free Report) , which is a # 2 (Buy) stock with a Value Score of A.
Shares of McKesson are currently trading at a forward earnings multiple of 14.44 and a PEG ratio of 1.43 compared to its industry's P/E and PEG ratios of 18.11 and 1.69, respectively.
MCK's price-to-earnings ratio has been as high as 15.66 and as low as 11.07, with a median of 13.97, while its PEG ratio has been as high as 1.56 and as low as 0.96, with a median of 1.43, all within the past year.
McKesson sports a P/B ratio of -42.74 as well; this compares to its industry's price-to-book ratio of 6.26. In the past 52 weeks, MCK's P/B has been as high as -24.38, as low as -59.10, with a median of -38.58.
These are only a few of the key metrics included in Cardinal Health and McKesson strong Value grade, but they help show that the stocks are likely undervalued right now. When factoring in the strength of its earnings outlook, CAH and MCK look like an impressive value stock at the moment.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Should Value Investors Buy Cardinal Health (CAH) Stock?
The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always looking at the latest trends in value, growth, and momentum to find strong picks.
Looking at the history of these trends, perhaps none is more beloved than value investing. This strategy simply looks to identify companies that are being undervalued by the broader market. Value investors use a variety of methods, including tried-and-true valuation metrics, to find these stocks.
Zacks has developed the innovative Style Scores system to highlight stocks with specific traits. For example, value investors will be interested in stocks with great grades in the "Value" category. When paired with a high Zacks Rank, "A" grades in the Value category are among the strongest value stocks on the market today.
Cardinal Health (CAH - Free Report) is a stock many investors are watching right now. CAH is currently sporting a Zacks Rank of #2 (Buy), as well as a Value grade of A. The stock is trading with a P/E ratio of 12.91, which compares to its industry's average of 18.11. CAH's Forward P/E has been as high as 14.81 and as low as 8.75, with a median of 11.06, all within the past year.
Investors will also notice that CAH has a PEG ratio of 1.11. This popular figure is similar to the widely-used P/E ratio, but the PEG ratio also considers a company's expected EPS growth rate. CAH's PEG compares to its industry's average PEG of 1.69. CAH's PEG has been as high as 8.89 and as low as 1.11, with a median of 2, all within the past year.
Another great Medical - Dental Supplies stock you could consider is McKesson (MCK - Free Report) , which is a # 2 (Buy) stock with a Value Score of A.
Shares of McKesson are currently trading at a forward earnings multiple of 14.44 and a PEG ratio of 1.43 compared to its industry's P/E and PEG ratios of 18.11 and 1.69, respectively.
MCK's price-to-earnings ratio has been as high as 15.66 and as low as 11.07, with a median of 13.97, while its PEG ratio has been as high as 1.56 and as low as 0.96, with a median of 1.43, all within the past year.
McKesson sports a P/B ratio of -42.74 as well; this compares to its industry's price-to-book ratio of 6.26. In the past 52 weeks, MCK's P/B has been as high as -24.38, as low as -59.10, with a median of -38.58.
These are only a few of the key metrics included in Cardinal Health and McKesson strong Value grade, but they help show that the stocks are likely undervalued right now. When factoring in the strength of its earnings outlook, CAH and MCK look like an impressive value stock at the moment.